Pharmaceutical Packaging Market Prospects – Innovations in Packaging and Drug Delivery
Download the Pharmaceutical Packaging Market Prospects Trend Report to explore the full report and delve into the evolving opportunities in pharmaceutical packaging and drug delivery.
As pharmaceutical companies shift toward more complex and personalised treatments, packaging innovation is becoming a critical factor in drug development. With biologics and targeted therapies gaining prominence, the need for packaging that accommodates unique delivery, storage, and patient usability requirements is accelerating.
Biologics – complex formulations that often require refrigeration and device-based delivery – are driving demand for cold chain-compatible, patient-friendly packaging solutions. Asmita Khanolkar of SMC Ltd. emphasizes the importance of tailored strategies for biologics, especially given the rise of self-administration and smaller patient populations for personalized treatments. Unlike mass-market drugs of the past, today’s therapies must be designed with precision and flexibility in mind.
The popularity of GLP-1 agonists, which are used to treat diabetes and obesity, underscores the growing market for high-value injectables. With forecasts estimating these drugs could generate over $100 billion by 2030, pharmaceutical companies are focusing more on delivery systems like autoinjectors and wearable devices. These solutions enhance ease of use and support home-based care – an increasingly important model as the global population ages.
Beyond biologics, packaging for oral formulations is evolving as well. Modified-release tablets, high-potency APIs, and orphan drugs are spurring demand for protective blister packs and containment solutions that ensure safety and compliance.
Digitisation is also transforming pharmaceutical packaging. AI and machine learning are being used to improve patient adherence through smart packaging, such as connected pill bottles and electronic dose tracking systems. These technologies can also enhance supply chain operations, personalize packaging design, and support sustainability goals by reducing waste and optimising materials.
Looking ahead, investments in advanced formulations – like long-acting injectables, microneedles, and implantable devices – are expected to grow. These innovations demand precise fill-finish technologies and scalable packaging processes. As the pharmaceutical landscape becomes more patient-centric and data-driven, packaging will play a central role in delivering both therapeutic effectiveness and improved user experiences.
In this evolving market, pharmaceutical packaging is no longer an afterthought – it’s a strategic asset that bridges therapy, technology, and patient needs.
Discover the full Pharmaceutical Packaging Market Prospects Trend Report here.
Related News
-
News Swiss pharma industry warns US tariffs could harm global patient care
The Swiss pharmaceutical sector has raised alarms over new US tariffs on medicines, warning of disrupted supply chains, increased costs, and delayed innovation, all of which could jeopardise patient access to essential treatments worldwide.
-
News Women in Pharma: CPHI India – India’s Pharmaceutical Industry and Gender Inclusion Challenges
India’s pharmaceutical industry has emerged as a significant player in the global market, valued at USD 50 billion in FY 2023-2024, according to Frost & Sullivan’s analysis. This sector encompasses a diverse portfolio, including drugs, vacc... -
News Biogen acquires Apellis Pharmaceuticals to boost immunology and rare disease profile
Biogen Inc. has announced its acquisition of Apellis Pharmaceuticals, Inc., a move that is set to significantly enhance its growth portfolio in immunology and rare diseases. The agreement, valued at approximately US$5.6 billion, will see Biogen purchas... -
News Gilead Sciences acquires Ouro Medicines for over US$2 billion
Gilead Sciences confirms a deal to take over Ouro Medicines, adding to a portfolio of therapies for autoimmune diseases.
-
News Women in Pharma: Advancing Women's Health
Discover the latest innovations in technologies and therapeutics that are revolutionising women's health in our latest CPHI Online Women in Pharma infographic.
-
News CPHI Pharma Awards 2026: Recognising Excellence in an Evolving Industry
Submissions now open — deadline May 16
-
News Dr Reddy's to launch generic semaglutide in India
Dr Reddy’s Laboratories, one of India’s leading pharmaceutical companies, is preparing to launch a generic version of semaglutide, branded as Obeda, in March. Obeda is expected to provide a more affordable alternative to Ozempic a... -
News Frontier Biotech and GSK Forge RNA Therapy Partnership
Frontier Biotechnologies and GSK have entered a global licensing agreement to advance small interfering RNA (siRNA) therapeutics. This collaboration grants GSK exclusive rights to develop and commercialise two promising siRNA candidates, marking a mile...